Publication at Faculty of Medicine in Hradec Králové |
2010
Abstract
The aim of the study was the monitoring of plasma levels of isoenzyme of creatine kinase(CKMB mass), myoglobin (MYO), BB isoenzyme of glycogen phosphorysase (GPBB), heart-type farry acid binding protein (H-FABP), carbonic anhydrase III (CA III), and cardiac troponin I (cTnl) in patients with acute myocardial infarction during 5 days as well screening of the sensitivity of the new technology of the protein biochip microarray that was used to assess plasma levels of these markers (System Evidence InvestigatorTM, Randox Laboratories Ltd., Great Britain).